Tuberculosis Death Epidemiology and Its Associated Risk Factors in Sabah, Malaysia
- PMID: 34574665
- PMCID: PMC8470141
- DOI: 10.3390/ijerph18189740
Tuberculosis Death Epidemiology and Its Associated Risk Factors in Sabah, Malaysia
Abstract
Tuberculosis (TB) is a leading killer from a single infectious agent globally. In 2019, Malaysia's TB incidence rate was 92 per 100,000 population, and the TB mortality rate was estimated at 4 cases per 100,000 population per year. However, the state of Sabah had a higher burden of TB with a notification rate of 128 per 100,000 population and a TB case fatality rate of 8% compared to the national figure. This study aims to provide a comprehensive report on TB deaths epidemiology and its associated factors at a sub-national level. This nested case-control study used Sabah State Health Department TB surveillance data from the Malaysia national case-based TB registry (MyTB) between 2014 and 2018. Cases were defined as all-cause TB deaths that occurred before anti-TB treatment completion from the time of TB diagnosis. Controls were randomly selected from TB patients who completed anti-TB treatment. The TB mortality rate had increased significantly from 9.0/100,000 population in 2014 to 11.4/100,000 population in 2018. The majority of TB deaths occurred in the first two months of treatment. TB-related deaths were primarily due to advanced disease or disseminated TB, whereas non-TB-related deaths were primarily due to existing comorbidities. Many important independent risk factors for TB deaths were identified which are useful to address the increasing TB mortality rate.
Keywords: Malaysia; Sabah; case fatality; mortality; tuberculosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization . Global Tuberculosis Report 2020. WHO; Geneva, Switzerland: 2020.
-
- World Health Organisation . The End TB Strategy. WHO; Geneva, Switzerland: 2015.
-
- Massavirov S., Akopyan K., Abdugapparov F., Ciobanu A., Hovhanessyan A., Khodjaeva M., Gadoev J., Parpieva N. Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013–2017. Int. J. Environ. Res. Public Health. 2021;18:4623. doi: 10.3390/ijerph18094623. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
